Schizophenia DisorderNCT07017881
The Effectiveness of Psychosocial Skills Training Applied to Individuals Diagnosed With Schizophrenia
A study testing Psychosocial Skills Training in people with Schizophenia Disorder and Psychiatric Nursing, run by Neslihan Lok at 1 site in Turkey (Türkiye).
Trial summary
This study was conducted to investigate the effects of Psychosocial Skills Training on subjective recovery, self-esteem and quality of life levels of schizophrenia patients. The research is a randomized controlled trial. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Schizophenia Disorder, Psychiatric Nursing, Psychosocial Skills Training
- What is being tested?
- Psychosocial Skills Training
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 48 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 5 Aug 2024to 18 Oct 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Being between the ages of 18-65,
- Having been diagnosed with Schizophrenia for at least 6 months according to ICD-10,
- Being registered with Selçuk University Medical Faculty Hospital Mental Health and Diseases Polyclinic,
- Coming to polyclinic check-ups regularly,
- Using antipsychotic medication regularly,
- Being at least a primary school graduate,
Who cannot join
- • Having an organic mental disorder or mental retardation,
- Having a visual or hearing impairment,
- Participating in a program similar to the intervention to be implemented.
- Not attending at least two sessions of Psychosocial Skills Training,
- Having an exacerbation period/hospitalization and experiencing a physical discomfort at a level that prevents attending sessions during the program process,
- Wanting to leave the study,
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Selcuk University Faculty of Medicine Hospital
Konya, Selçuklu
About this study
Official title: The Effect of Psychosocial Skills Training Applied to Individuals Diagnosed With Schizophrenia on Subjective Recovery, Self-Esteem and Quality of Life Levels
This study was conducted to investigate the effects of Psychosocial Skills Training on subjective recovery, self-esteem and quality of life levels of schizophrenia patients. The research is a randomized controlled trial. The research was conducted with 48 schizophrenia patients (Experimental: 24, Control: 24) registered in the Mental Health and Diseases Outpatient Clinic of a hospital. Personal Information Form, Subjective Recovery Assessment Scale, Rosenberg Self-Esteem Scale, Quality of Life Scale for Schizophrenia Patients were used to collect data. Data were collected by the researcher using the self-reporting face-to-face interview method in the form of pre-test and post-test. Psychosocial Skills Training was applied to the patients in the experimental group, one session per week, two days a week for 11 weeks, while the patients in the control group did not receive any intervention.
- Being tested
- Psychosocial Skills Training
- Keywords
- schizophenia disorder, psychiatric nursing, Psychosocial skills training, quality of life, self-esteem, Subjective improvement
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Psychosocial Skills TrainingBehavioural
The 24-person intervention group was divided into three separate groups of 8 people (Group 1, Group 2, Group 3). Group 1 and Group 2 attended sessions on Tuesdays at different times, while Group 3 attended sessions on Thursdays. Psychosocial Skills Training consisted of eleven sessions in total, one session per week. Sessions lasted an average of 60 minutes for each group. In each session, 5-10 minute breaks were given for rest and eating and drinking, considering the attention span and fatigue of the patients. Psychosocial Skills Training was applied two days a week (Group 1-2: Tuesday, Group 3: Thursday) in order to ensure that the patients could get more benefit from the application.
| Study group | Role | What they receive |
|---|---|---|
| control group | No intervention | No intervention was applied. They continued their routine outpatient clinic check-ups and treatments. |
| intervention group | Experimental | The intervention group is a group of 24 schizophrenia patients who received 11 weeks of Psychosocial Skills Training. Receives: Behavioral: Psychosocial Skills Training |
What is being measured
The primary outcome is the main question the study is designed to answer.
Subjective Improvement Total Score Average
The scale is evaluated based on the total score and the total score varies between 17-85. Higher scores obtained from the scale indicate that the individual perceives himself/herself as better recovered.
Measured: 11 weeks from pre-test to end of training
Secondary outcomes (2)
Rosenberg Self-Esteem Scale Society Score Average
The scale score varies between 0 and 6 points. A score between 0 and 1 indicates "high self-esteem", a score between 2 and 4 indicates "medium self-esteem", and a score between 5 and 6 indicates "low self-esteem".
Measured: 11 weeks from pre-test to end of training
Quality of Life Scale Total Score Average for Schizophrenia Patients
High scores (5-6) obtained from the scale indicate high quality of life and good adaptation, while low scores (0-1) reflect low quality of life and poor adaptation.
Measured: 11 weeks from pre-test to end of training
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Jun 2025
- Study start5 Aug 2024
- Primary completion9 Aug 2024
- Study completion18 Oct 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Schizophenia DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The sample group was determined as 48 in total, 24 intervention and 24 control. Individuals were assigned to the intervention and control groups using the simple randomization method. The program was asked to randomly divide the files into two groups of 24 people each. The researcher randomly determined these two groups as the intervention (Set 1) and control (Set 2) groups. The 24 individuals constituting the intervention group were assigned to 3 separate groups of 8 people each (Group 1, Group 2, Group 3) using the block randomization method. In addition to their routine treatments, the intervention group received one session of psychosocial skills training per week. The control group continued their routine treatments.
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 48 participants (actual)
Sponsor and investigators
- Lead sponsor
- Neslihan Lok
- Sponsor type
- University, hospital or other
- Collaborators
- Selcuk University
- Responsible party
- Sponsor-investigator, Neslihan Lok, Selcuk University
- Investigators
- Neslihan LÖK, Prof. Dr., Study director, Selcuk University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07017881
- Sponsor's protocol ID
- SELCUKU-ANCANDAN-001
- Status last verified
- Jun 2025
- First submitted
- 25 May 2025
- Last updated
- 12 Jun 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Psychosocial Skills Training Applied to Individuals Diagnosed With Schizophrenia on Subjective Recovery, Self-Esteem and Quality of Life Levels
- ClinicalTrials.gov ID
- NCT07017881
- Acronym / sponsor ID
- SELCUKU-ANCANDAN-001
- Keywords
- schizophenia disorder, psychiatric nursing, Psychosocial skills training, quality of life, self-esteem, Subjective improvement
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 48 participants (actual)
- Lead sponsor
- Neslihan LokUniversity, hospital or other
- Collaborators
- Selcuk University
- Study start
- 5 Aug 2024 (actual)
- Primary completion
- 9 Aug 2024 (actual)
- Study completion
- 18 Oct 2024 (actual)
- First posted
- 12 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study was conducted to investigate the effects of Psychosocial Skills Training on subjective recovery, self-esteem and quality of life levels of schizophrenia patients. The research is a randomized controlled trial. The research was conducted with 48 schizophrenia patients (Experimental: 24, Control: 24) registered in the Mental Health and Diseases Outpatient Clinic of a hospital. Personal Information Form, Subjective Recovery Assessment Scale, Rosenberg Self-Esteem Scale, Quality of Life Scale for Schizophrenia Patients were used to collect data. Data were collected by the researcher using the self-reporting face-to-face interview method in the form of pre-test and post-test. Psychosocial Skills Training was applied to the patients in the experimental group, one session per week, two days a week for 11 weeks, while the patients in the control group did not receive any intervention.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
- Model description
- The sample group was determined as 48 in total, 24 intervention and 24 control. Individuals were assigned to the intervention and control groups using the simple randomization method. The program was asked to randomly divide the files into two groups of 24 people each. The researcher randomly determined these two groups as the intervention (Set 1) and control (Set 2) groups. The 24 individuals constituting the intervention group were assigned to 3 separate groups of 8 people each (Group 1, Group 2, Group 3) using the block randomization method. In addition to their routine treatments, the intervention group received one session of psychosocial skills training per week. The control group continued their routine treatments.
| Arm | Type | Receives |
|---|---|---|
| control group | No intervention | –No intervention was applied. They continued their routine outpatient clinic check-ups and treatments. |
| intervention group | Experimental | Behavioral: Psychosocial Skills TrainingThe intervention group is a group of 24 schizophrenia patients who received 11 weeks of Psychosocial Skills Training. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Being between the ages of 18-65,
- Having been diagnosed with Schizophrenia for at least 6 months according to ICD-10,
- Being registered with Selçuk University Medical Faculty Hospital Mental Health and Diseases Polyclinic,
- Coming to polyclinic check-ups regularly,
- Using antipsychotic medication regularly,
Key exclusion criteria (6 listed)
- • Having an organic mental disorder or mental retardation,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Psychosocial Skills TrainingThe 24-person intervention group was divided into three separate groups of 8 people (Group 1, Group 2, Group 3). Group 1 and Group 2 attended sessions on Tuesdays at different times, while Group 3 attended sessions on Thursdays. Psychosocial Skills Training consisted of eleven sessions in total, one session per week. Sessions lasted an average of 60 minutes for each group. In each session, 5-10 minute breaks were given for rest and eating and drinking, considering the attention span and fatigue of the patients. Psychosocial Skills Training was applied two days a week (Group 1-2: Tuesday, Group 3: Thursday) in order to ensure that the patients could get more benefit from the application. | Behavioural | intervention group |
Primary outcome
Subjective Improvement Total Score Average
Time frame: 11 weeks from pre-test to end of training
The scale is evaluated based on the total score and the total score varies between 17-85. Higher scores obtained from the scale indicate that the individual perceives himself/herself as better recovered.
2 secondary outcomes
Rosenberg Self-Esteem Scale Society Score Average
Time frame: 11 weeks from pre-test to end of training
Quality of Life Scale Total Score Average for Schizophrenia Patients
Time frame: 11 weeks from pre-test to end of training
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Jun 2025.
- Individual participant dataSharing planned: No
Related trials for Schizophenia Disorder
Not yet recruiting
Effect of Occupational Therapy on Psychosocial Parameters and Functioning in Individuals With Severe Mental Illness
Schizophenia Disorder, Severe Mental Illness
Not yet recruiting
Motivational Intervention for Patients With Schizophrenia
Schizo-affective Disorder, Non Organic Psychosis
RecruitingPhase 4
Biomarkers to Enhance Early Schizophrenia Treatment
Schizophenia Disorder
Active, not recruitingObservational study
Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections: Translating Epidemiology to Deep-phenotyping.
Anxiety, Depression - Major Depressive Disorder
RecruitingPhase 4
Exercise and Olanzapine-samidorphan
Schizophenia Disorder, Schizoaffective Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Neslihan LÖK, Prof. Dr. study director
Selcuk University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Psychosocial Skills Training in people with Schizophenia Disorder and Psychiatric Nursing, run by Neslihan Lok at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Subjective Improvement Total Score Average (time frame: 11 weeks from pre-test to end of training). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jun 2025.